tirzepatide hfpef ESC 2025: study supports use of semaglutide, in cardiometabolic patients Has Tirzepatide Scaled the HFpEF/Obesity

GLP-1s are providing better weight-loss outcomes than the previous AOMs

Eat enough protein even when youre not hungry

Who is eligible for Low Calorie Diet (LCD)

At the 2023 ADA Scientific Sessions in San Diego this week, researchers unveiled full results of the SURMOUNT-2 clinical trial evaluating tirzepatide for weight loss in adults with obesity or overweight and type 2 diabetes

18 26 These case reports uniformly cited the circumstance of a patient whose therapeutic dose of a susceptible drug was stabilized, who subsequently showed serious toxicity that occurred after several days of simultaneous intake of the drug and grapefruit in a normal or high quantity

the answer is that while theres no hard-and-fast rule against it, you should proceed with extreme caution and with the full guidance of a medical professional